This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: National Institute of Health and Medical Research, Societe Civile Bioprojet, Bioprojet. Active years: 1987-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gif, FR (1988)
- Gif /Yvette, FR (1987 - 1994)
- Gif Sur Yvette, FR (1991 - 2001)
- Dourdon, FR (2011)
- Dourdan, FR (2006 - 2012)
- Dourdan, ES (2013)
Company Filing History:
7 out of 1,853 
7 out of 20 
2 out of 24 
Years Active: 1987-2013
Title: **Jean-Michel Arrang: Innovator in Sleep Apnea Treatment**
Introduction
Jean-Michel Arrang is an accomplished inventor based in Dourdan, France, recognized for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 13 patents, Arrang has made strides in the field of medicinal chemistry, particularly in treatments related to sleep apnea. His unique inventions focus on improving the efficacy of therapeutic compounds.
Latest Patents
Among his notable inventions is the crystalline monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine. This compound provides a method for treating sleep apnea and other related conditions. The innovation details an effective administration of a crystalline form of the compound, which has a specific X-ray diffractogram characterized by peaks at 11.2°, 19.9°, 20.7°, and 34.1° ± 0.2°.
Another patent from Arrang includes the new crystalline form of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, along with its manufacturing processes and potential uses in medical compositions. These innovative formulations are key in addressing various ailments, particularly sleep-related disorders.
Career Highlights
Throughout his career, Jean-Michel Arrang has worked with renowned organizations, such as Société Civile Bioprojet and the Institut National De La Santé et de la Recherche Médicale (INSERM). His collaborations in these esteemed institutions highlight his commitment to research and development in medical therapeutics.
Collaborations
Arrang has partnered with prominent colleagues, including Jean-Charles Schwartz and Monique Garbarg. These collaborations have been instrumental in advancing the collective knowledge and capabilities in the field of pharmaceutical innovations.
Conclusion
Jean-Michel Arrang's contributions to medicinal chemistry, particularly in the treatment of sleep apnea, underscore his role as a significant inventor. With his innovative patents and collaborative efforts, he continues to make impactful advancements that can greatly enhance patient care and treatment options in the medical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile